Skip to main content

Approaching Regulatory Approval of Cardiovascular Regenerative Therapy.

Publication ,  Journal Article
Povsic, TJ
Published in: Circ Res
February 16, 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Res

DOI

EISSN

1524-4571

Publication Date

February 16, 2018

Volume

122

Issue

4

Start / End Page

552 / 554

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Regenerative Medicine
  • Humans
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Povsic, T. J. (2018). Approaching Regulatory Approval of Cardiovascular Regenerative Therapy. Circ Res, 122(4), 552–554. https://doi.org/10.1161/CIRCRESAHA.117.312520
Povsic, Thomas J. “Approaching Regulatory Approval of Cardiovascular Regenerative Therapy.Circ Res 122, no. 4 (February 16, 2018): 552–54. https://doi.org/10.1161/CIRCRESAHA.117.312520.
Povsic TJ. Approaching Regulatory Approval of Cardiovascular Regenerative Therapy. Circ Res. 2018 Feb 16;122(4):552–4.
Povsic, Thomas J. “Approaching Regulatory Approval of Cardiovascular Regenerative Therapy.Circ Res, vol. 122, no. 4, Feb. 2018, pp. 552–54. Pubmed, doi:10.1161/CIRCRESAHA.117.312520.
Povsic TJ. Approaching Regulatory Approval of Cardiovascular Regenerative Therapy. Circ Res. 2018 Feb 16;122(4):552–554.

Published In

Circ Res

DOI

EISSN

1524-4571

Publication Date

February 16, 2018

Volume

122

Issue

4

Start / End Page

552 / 554

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Regenerative Medicine
  • Humans
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences